Effect of cholesteryl ester transfer protein inhibitor on vitamin E transport should be studied

Am Heart J. 2009 Jul;158(1):e11; author reply e13. doi: 10.1016/j.ahj.2009.05.004.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticholesteremic Agents / adverse effects*
  • Anticholesteremic Agents / therapeutic use
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors*
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Humans
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / drug therapy*
  • Oxazolidinones / adverse effects*
  • Oxazolidinones / therapeutic use
  • Quinolines / adverse effects
  • Quinolines / therapeutic use
  • Treatment Outcome
  • Triglycerides / blood
  • Vitamin E / metabolism*

Substances

  • Anticholesteremic Agents
  • CETP protein, human
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Oxazolidinones
  • Quinolines
  • Triglycerides
  • Vitamin E
  • torcetrapib
  • anacetrapib